+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Organ and Tissue Transplantation - Global Strategic Business Report

  • ID: 595578
  • Report
  • November 2016
  • Region: Global
  • 266 Pages
  • Global Industry Analysts, Inc
1 of 5

FEATURED COMPANIES

  • Acelity L.P. Inc. (US)
  • CryoLife, Inc. (US)
  • Exactech, Inc. (US)
  • Medtronic, plc. (Ireland)
  • Organogenesis, Inc. (US)
  • MORE
This report analyzes the worldwide markets for Organ and Tissue Transplantation in number of organs transplanted. The Global and regional markets (except the US) for Organ and Tissue Transplantation in this report are analyzed by the following Product Segments - Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, Lungs, and Corneal Transplantation). The US market for Organ and Tissue Transplantation in this report is analyzed by the following Product Segments: Organ Type (In Volume and Value) (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Volume Only) (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (Volume Only) (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 22 companies including many key and niche players such as -

Acelity L.P. Inc.
CryoLife, Inc.
Exactech, Inc.
Folio Biosciences, LLC
Dr. Franz Kohler Chemie GmbH
Note: Product cover images may vary from those shown
2 of 5

Loading
LOADING...

3 of 5

FEATURED COMPANIES

  • Acelity L.P. Inc. (US)
  • CryoLife, Inc. (US)
  • Exactech, Inc. (US)
  • Medtronic, plc. (Ireland)
  • Organogenesis, Inc. (US)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definition and Scope of Study
Organ Transplantation
Heart Transplantation
Kidney Transplantation
Liver Transplantation
Pancreas Transplantation
Small Intestine Transplantation
Lungs
Tissue Transplantation
Corneal Transplantation
Blood Stem Cell Transplantation
Bone Marrow Transplantation
Heart Valves Transplantation

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Market Outlook
Current & Future Analysis
A Review of Organ Donors Worldwide
Table 1: Global Organ Transplants Market (2014 & 2015): Number of Deceased Organ Donors per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Table 2: Global Organ Transplants Market (2014 & 2015): Number of Living Organ Donors per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Kidney and Liver Transplants Top the Organ Transplants Worldwide
Table 3: Global Kidney Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Table 4: Global Kidney Transplants Market (2014): Number of Living Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Table 5: Global Liver Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Table 6: Global Liver Transplants Market (2014): Number of Living Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Table 7: Global Heart Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Table 8: Global Lung Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Table 9: Global Pancreas Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
Demand and Supply Imbalance
Measures to Address Organ Shortage
Cardiac Arrest Death Patients: The Untapped Potential Donors
Table 10: Global Organ Transplants Market (2014): Number of Actual Donors After Cardiac Death per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
Donation after Circulatory Death
Rife with Ethical Issues
Transplantation
Expenditure and Regional Variations
Table 11: US Organ Transplantation Charges
Total Billed Charges per Transplant by Type (2014) (includes corresponding Graph/Chart)
Bone Grafts: An Overview
Table 12: Fractures by Age Group (2014): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart)
Table 13: Global Orthopedic Market by Segment (2015E): Percentage Breakdown of Value Sales for Extremities, Hips, Knees, Orthobiologics, Spine, Trauma and Others (includes corresponding Graph/Chart)
Orthopedic Grafts
Regional Market Variations

2. MARKET TRENDS
Combined Organ Transplantation
Gaining Attention
Table 14: Multiple Organ Transplants in the US
No. of Transplants by Type (2014- 2016) (includes corresponding Graph/Chart)
Illegal Organ Trafficking
A Risky Proposition
Transplant Tourism
Creating Brighter Avenues
Graying Population and Chronic Diseases Surge Need for Transplants
Global Aging Population Statistics
Opportunity Indicators
Table 15: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart)
Table 16: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Table 17: Life Expectancy at Age 60 and 80 Years
(2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Table 18: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart)
Optimization Strategies for Organs Catch Attention and Supply
Demand Gap Widens
Advent of Innovative Devices Mitigate Chances of Organ Damages
Shortage of Organs Propels Research on Xenotransplantation
A Peek into the Organ Transplant Immunosuppressants Market
Market to Come Under Tremendous Pressure
Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue Transplantation
Table 19: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart)
Fetal Tissue for Bionic Devices
Assuming Importance
LVADs
Gaining Significance for Impending Heart Transplants
Synthetic Bone Graft
The Latest Trend
Stem Cell Therapies
Expanding the Horizon of Transplantation
Rising Cancer Incidence to Drive Stem Cell Transplants
Table 20: Number of New Cancer Cases Worldwide by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition
Bone Morphogenetic Protein
Safety Concerns Affect Growth Prospects
Dental Bone Grafting
A High Potential Market
Table 21: Dental Tissue & Bone Regeneration Materials Market (2015): Percentage Share Breakdown by Segment for Allografts, Synthetics, and Xenografts (includes corresponding Graph/Chart)
Key Recent Technological Innovations
3-D Bioprinting
Preloaded Corneal Tissue Cartridges
Lung Perfusion Technology

3. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET
Organ Rejection
A Major Barrier to Transplantation
Scarcity of Donor Organs
A Stumbling Block in Organ Transplantation
Other Issues for Organ Transplantation
Ethical Concerns in Transplants
Bioethical Issues Hinder Organ Donation Process
Lack of Requisite Expertise
Hindering Implantation Process
Corneal Transplantation in Developing Countries: Key Challenges

4. PRODUCT OVERVIEW
Organ and Tissue Transplantation
Organ Transplantation
Heart Transplantation
Heart Diseases and Disorders
Post-Operative Complications and Consequences of Heart Transplants
Bleeding
Infection
Arrhythmia
Heart Attack
Coronary Artery Disease
Respiratory Dysfunction
Renal Dysfunction
Graft Rejection and Dysfunction
Death
Kidney Transplantation
Kidney Disorders and Diseases
Donor Evaluation
Waiting List
Surgery/Post-Operation
Post-Operative Supervision and Issues
Liver Transplantation
Liver Disorders and Diseases
Pancreas Transplantation
Post-Operative Complications and Consequences of Pancreas Transplants
Small Intestine Transplantation
Intestine Disorders and Diseases
Lung Transplantation
Lung Diseases and Disorders
Lung Patients Survival Statistics
Heart-and-Lung Transplantation
Tissue Transplantation
Types of Grafts
Autograft
Allograft / Homograft
Transplant Tolerance
Isograft
Xenograft
Corneal Transplantation
Penetrating Keratoplasty
Lamellar (Non-Penetrating) Keratoplasty
Aftercare
Risks Associated with Corneal Transplants
Transplantation Outcomes
Morbidity and Mortality Rates
Alternatives
Blood Stem Cells
Peripheral Blood Stem Cell Transplant
Umbilical Cord Blood Stem Cell Transplant
Bone Marrow and Hematopoietic Stem Cells
Bone and Tissue Transplantation
Bone Marrow Transplants
Stem Cell Therapy
Human Heart Valves
Atrioventricular Valves
Mitral Valve
Tricuspid Valve
Semilunar Valves
Aortic Valve
Pulmonic Valve
Pathology of Valves
Prosthetic Heart Valves
Prosthetic Mechanical Valve
Advantages
Disadvantages
Prosthetic Biologic Valve
Advantages
Disadvantages
Fetal Cells
Fetal Tissue for Transplantation
Storage Duration Time
Storage Time Period for Organs and Tissues
Cold Ischemia Time
Transplantation Immunology
Acute Cellular Rejection
Chronic Rejection
Post-Transplant Observations
Types of Donors
Alive Donors
Related Donors
Good Samaritans
Rewarded/Forced Donors
Deceased Donors
Directed / Allocated
Organs and Tissues Transplanted by Type of Donor
Organ/Tissue Donation and Eligibility Criteria
Factors Considered for Matching Recipients to Donor Organs
Testing
Blood Typing
Tissue Typing
Histocompatibility
A Major Barrier for Organ Transplantation
Transplantation
Safety Requirements
Waiting List
Active Waiting List Patients
Inactive Waiting List Patients
History
Major Milestones in Organ Transplantation

5. ARTIFICIAL ORGANS
AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS
Artificial Organs Revolutionize Medical Technology Industry
Artificial Organs
Categorization of Artificial Organs
External Artificial Organs
Internal or Implantable Artificial Devices
Artificial Heart
Total Artificial Heart (TAH)
Ventricle Assist Device (VAD)
Right Ventricular Assist Systems (RVAS)
Left Ventricular Assist Systems (LVAS)
Select Ventricular Assist Devices
Artificial Kidney (Dialyzer)
Limitations of Artificial Kidney
Artificial Liver
Select Liver Assist Devices
Categorization of Liver Devices
Mechanical Systems
Bio-Artificial Systems
Artificial Pancreas
Artificial Lungs (Oxygenator)
Types of Artificial Lung
Artificial Cornea
Keratoprostheses
Tissue Engineered Corneas
Artificial Skin/Skin Replacement Products
AlloDerm Regenerative Tissue Matrix
Apligraf
Cymetra Micronized AlloDerm Tissue
Dermagraft
Epicel
Integra Products
OrCel
TransCyte
Core Competitive Factors
Market Outlook for Artificial Organs

6. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS
Organ Preservation Solutions
Celsior Solution
Collins Solution
Euro Collins Solution
Custodiol® HTK Solution
Hypothermosol
ViaSpan
Immunosuppressant Drugs
Antibody Products for Treatment of Organ Transplant Rejection
Antithymocyte Globulin
ATGAM
Thymoglobulin
Therapeutic Antibody Products
Antiproliferative Agents
Azathioprine
CellCept
Certican
Myfortic
Calcineurin Inhibitors
Cyclosporine
Gengraf
Neoral
Prograf (Tacrolimus)
TOR Inhibitors
Side Effects of Immunosuppression Therapy

7. REGULATORY ENVIRONMENT
Transplant Center
Organ Procurement Organization (OPO)
Health Resources and Services Administration (HRSA)
Division of Transplantation (DoT)
United Network for Organ Sharing (UNOS)
Organ Procurement and Transplantation Network (OPTN)
University Renal Research and Education Association (URREA)
Scientific Registry of Transplant Recipients (SRTR)
Funding Sources
Patient Education and Advocacy Organizations
Legal Framework for Transplantation
Legislation Covering Organ Transplant
Organ Transplantation and Ethics

8. RECENT INDUSTRY ACTIVITY
Paragonix Technologies and Waters Medical Systems Enter into Product Supply Agreement
Medtronic Announces Availability of Beacon Heart Failure Management Service
Paragonix Technologies and Essential Pharmaceuticals Enter into Product Supply Agreement
LeMaitre Vascular Acquires ProCol® Distribution Rights and Purchase Option
Merit Medical Systems Purchases HeRO Graft Product Line of CryoLife
CryoLife Takes Over On-X Life Technologies
Medtronic Obtains FDA Clearance on Infuse® Bone Graft
Veloxis Pharmaceuticals Introduces Envarsus® XR for Kidney Transplant Treatment
Organogenesis Obtains Marketing Authorization on Apligraf® Wound Healing Technology
Medtronic Plc Introduces Medtronic CoreValve® System for Everyday Clinical Experience
Genomic Data Sciences Releases Unique Human Leukocyte Antigen (HLA) Typing Software Solution
St. Jude to Acquire Thoratec
Lifeline Scientific Obtains CFDA Clearance for Commercial Sale of Clinical Organ Preservation and Flush Solutions
Organovo and Yale Team Up to Develop Bioprinted Tissues for Surgical Transplantation
ThermoGenesis and TotipotentRX Complete 20th Pediatric BMT
LifeCell Acquires Adipose Tissue Injector from Tau Tona Group
AlloSource Introduces AlloMend™
Synergy Biomedical Launches Bonegraft Product BioSphere Putty
K2M Launches Venado Bonegraft Systems
OTS Launches LifeCradle® Heart Perfusion System
FBiH Signs Agreement with Croatia
AlloSource and HumaCyte Enter Manufacturing Agreement
PSF Partners with MTF for Research Grants

9. FOCUS ON SELECT PLAYERS
Acelity L.P. Inc. (US)
CryoLife, Inc. (US)
Exactech, Inc. (US)
Folio Biosciences, LLC (US)
Dr. Franz Kohler Chemie GmbH (Germany)
Medtronic, plc. (Ireland)
Organogenesis, Inc. (US)
Organ Recovery Systems (US)
Organ Transport Systems (US)
XVIVO Perfusion AB (Sweden)
10. GLOBAL MARKET PERSPECTIVE
Table 22: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 23: World Historic Review for Organ Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 24: World 14-Year Perspective for Organ Transplantation by Geographic Region
Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 25: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 26: World Historic Review for Heart Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 27: World 14-Year Perspective for Heart Transplantation by Geographic Region
Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 28: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 29: World Historic Review for Kidney Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 30: World 14-Year Perspective for Kidney Transplantation by Geographic Region
Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 31: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 32: World Historic Review for Liver Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 33: World 14-Year Perspective for Liver Transplantation by Geographic Region
Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 34: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 35: World Historic Review for Pancreas Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 36: World 14-Year Perspective for Pancreas Transplantation by Geographic Region
Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 37: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 38: World Historic Review for Lung Transplantation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 39: World 14-Year Perspective for Lung Transplantation by Geographic Region
Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 40: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region
US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 41: World Historic Review for Corneal Transplantation by Geographic Region
US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 42: World 14-Year Perspective for Corneal Transplantation by Geographic Region
Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current & Future Analysis
Organ Transplant Sector Holds Growth Potential
Table 43: US Organ Donors by Type
Kidney, Liver, Heart, Lung, and Pancreas for the Years 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 44: The US Bone Marrow Donor Registry: Percentage Breakdown of Adult Donors and Cord Blood Units by Race/Ethnicity (includes corresponding Graph/Chart)
Table 45: The US Kidney Donations by Donor Type (Deceased and Living): Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 46: The US Liver Donations by Donor Type (Deceased and Living): Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 47: The US Heart Donations by Donor Type
Deceased and Living: Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 48: The US Lung Donations by Donor Type
Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 49: The US Pancreas Donations by Donor Type
Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 50: The US Intestines Donations by Donor Type
Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 51: The US Intestinal Transplants by Donor Type
Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
Table 52: The US Deceased Organ Donors (2016): Percentage Breakdown of Donors by Age Group (includes corresponding Graph/Chart)
Table 53: The US Live Organ Donors (2016): Percentage Breakdown of Donors by Age Group (includes corresponding Graph/Chart)
Table 54: The US Organ Transplant Market by Race (2015): Percentage Breakdown of Donors and Recipients for African-Americans, Caucasians, Hispanics and Others (includes corresponding Graph/Chart)
Waiting List for Organ Transplants in the US
Table 55: Waiting List of Patients for Organ Transplants in the US by Organ Type: As of November, 2016 (includes corresponding Graph/Chart)
Select Market Trends
Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants
Table 56: ESRD Patient Prevalence in the US (2009-2014) (includes corresponding Graph/Chart)
Innovative Education Programs Contribute to Higher Organ Donors
Awareness Programs to Address Shortage of Minority Donors
US Organ Procurement Organizations by State
KPD Enables Compatibility Factor for Kidney Transplants
Tissue Transplantation in the US
Dental Bone Graft Substitutes Market: An Overview
Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials Market
Rising Incidence of Degenerative Intervertebral Disc Diseases
Opportunity Indicators for Bone Grafts
Osteoporosis
Table 57: Osteoporosis Population in the US: 2002, 2005, 2008 & 2012 (includes corresponding Graph/Chart)
Table 58: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart)
Regulatory Bodies
The United Network for Organ Sharing
The American Association of Tissue Banks (AATB)
Accredited Banks from Select US States
Eye Banks from Select US States
National Organ Transplant Act (NOTA)
Good Tissue Practices
Tissue Banking Regulation
FDA Regulations on Xenograft
DBM-based Products in US
Synthetic Bone Graft Substitutes
Strategic Corporate Developments
Select Key Players
B.Market Analytics
By Value Sales
Table 59: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 60: The US Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 61: The US 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 62: The US Recent Past, Current & Future Analysis for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 63: The US Historic Review for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
By Number of Procedures
Table 64: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 65: The US Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 66: The US 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 67: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type
Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 68: The US Historic Review for Tissue Transplantation by Tissue Type
Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 69: The US 14-Year Perspective for Tissue Transplantation by Tissue Type
Percentage Breakdown of Number of Procedures for Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 70: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type
Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 71: The US Historic Review for Bone Graft Transplantation by Graft Type
Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 72: The US 14-Year Perspective for Bone Graft Transplantation by Graft Type
Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 73: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application
General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 74: The US Historic Review for Bone Graft Transplantation by Application
General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 75: The US 14-Year Perspective for Bone Graft Transplantation by Application
Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current & Future Analysis
Canadians More Receptive to Organ Transplants
Table 76: Canadian Transplantation Market by Organ (2014): Percentage Breakdown of Number of Procedures for Hearts, Kidneys, Liver, Lungs and Pancreas (includes corresponding Graph/Chart)
Table 77: Canadian Organ Donors by Donor Type
Deceased and Living for Years 2011
2014 (includes corresponding Graph/Chart)
Table 78: Canadian Deceased Organ Donors by Age Group (2011-2014) (includes corresponding Graph/Chart)
Table 79: Canadian Living Organ Donors by Age Group (2011-2014) (includes corresponding Graph/Chart)
Waiting List
Table 80: Canadian Patients on Active Waiting List for Organ Transplants by Type: 2014 (includes corresponding Graph/Chart)
Success Rate of Organ Transplants
Table 81: Success Rate of Organ Transplants after 1-Year (includes corresponding Graph/Chart)
Favorable Growth Prospects in Bone Graft Substitutes Market
B.Market Analytics
Table 82: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 83: Canadian Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 84: Canadian 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current & Future Analysis
Terumo Corporation (Japan)
A Key Player
B.Market Analytics
Table 85: Japanese Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 86: Japanese Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 87: Japanese 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current & Future Analysis
Table 88: European Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
Table 89: European Multi-Organ Donors in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
Table 90: European Living Organ Donor Per Million Population (PMP) by Country for 2013 & 2014 (includes corresponding Graph/Chart)
Table 91: European Organ Transplantation by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
Table 92: European Organ Transplantation Waiting Lists: No. of Waiting Patients by Organ Type (As of Month End
October 2015 and 2016) (includes corresponding Graph/Chart)
Table 93: European Organ Transplantation Waiting List by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
Policy Changes
Key to Bridge Variability in Kidney Donors and Transplants across Europe
Focus on Select Regions
The United Kingdom
The UK Organ Transplantation System: An Overview
Table 94: Organ Donation in the UK by Type: Number of Deceased and Living Donors for Years 2013-14 through 2016-17 (includes corresponding Graph/Chart)
Table 95: Organ Donation in the UK by Country (2013-14 through 2016-17): Number of Donors by Type for England, Scotland, Norther Ireland and Wales (includes corresponding Graph/Chart)
Table 96: UK Organ Transplantation Market: Number of Transplants by Donor Type for Years 2013-14 through 2016-17 (includes corresponding Graph/Chart)
Table 97: UK Deceased Donor Organ Transplants: Number of Transplants by Organ Type for Years 2013-14 through 2015-16 (includes corresponding Graph/Chart)
Table 98: UK Organ Transplantation Market by Country (2013-14 through 2016-17): Number of Transplants by Type for England, Scotland, Norther Ireland and Wales (includes corresponding Graph/Chart)
Table 99: UK Organ Transplantation Waiting List: 2013-14 through 2016-17 (includes corresponding Graph/Chart)
Table 100: UK Organ Transplant Waiting List by Organ Types: 2014-15 through 2016-17 (includes corresponding Graph/Chart)
Table 101: Organ Donation in the UK (2015): Percentage Breakdown of Number of Donors by Age Group (includes corresponding Graph/Chart)
Spain
Organ Transplantation in Spain
France
Italy
Surge in Organ Transplants
Russia
Organ Transplantations Show a Downward Trend in Russia
Turkey
Table 102: Turkey
High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart)
Akdeniz University
A World-Renowned Transplantation Center
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 103: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 104: European Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 105: European 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Table 106: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2013 & 2015 (includes corresponding Graph/Chart)
Table 107: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2013 & 2015 (includes corresponding Graph/Chart)
Thriving Orthopedic Biomaterials Market in Asia-Pacific
Focus on Select Regions
Australia
One of the Major Organ Transplant Markets in Asia-Pacific
Key Facts on Organ and Tissue Transplantation in Australia
Organ Transplantations Reach Record Highs
Table 108: Organ Donors in Australia by Type: Number of Consented and Actual Donors Years 2009, 2012 & 2015 (includes corresponding Graph/Chart)
Table 109: Organ Transplantation in Australia: Number of Organ Recipients and Transplantations for Years 2009 through 2015 (includes corresponding Graph/Chart)
Table 110: Organ Transplantation in Australia by Organ Type (2015): Number of Transplants for Heart, Kidney, Liver, Lung and Pancreas (includes corresponding Graph/Chart)
Table 111: Organ Transplantation Waiting in Australia by Organ Type: 2014 (includes corresponding Graph/Chart)
Table 112: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart)
Table 113: Live Tissue Donations in Australia by Type (2013-2015): Number of Donations for Cardiovascular and Musculoskeletal Tissues (includes corresponding Graph/Chart)
Table 114: Deceased Tissue Donations in Australia by Type (2013-2015): Number of Organ & Tissue, and Tissue Only Donations for Cardiovascular, Musculoskeletal, Pancreas and Skin Tissues (includes corresponding Graph/Chart)
Government Efforts Key for Improving Organ Donation Activity
Government Mulls Easing Registration Process Further
China
Chinese Organ Transplant Market
Embroiled in Controversy
Transplantation Tourism in China
Low Transplant Success Rate Due to Unskilled Professionals
Illegal Activities for Harvesting Organs in China
Regulations on Organ Transplantation
Regulations on Brain Death
India
Organ Transplantation in India
Present Status
Table 115: Indian Organ Transplantation Market (2015): Current Requirement in Number of Organs by Type (includes corresponding Graph/Chart)
Table 116: Indian Organ Transplantation Market (2015): Number of Transplantations by Organ Type (includes corresponding Graph/Chart)
Rise in Medical Tourism Drives Bone Grafts Market
Aging Population Boosts the Indian Orthopedic Market
Overview of Renal Transplantation
Structural Deficiencies Affecting Indian Organ Donation Space
Singapore
Awareness Programs to Increase Living Kidney Donations in Singapore
Strategic Corporate Developments
B.Market Analytics
Table 117: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 118: Asia-Pacific Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 119: Asia-Pacific 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. LATIN AMERICA
A.Market Analysis
Current & Future Analysis
Brazil
A Major Transplant Market
Dental Bone Graft Substitutes Market
Overview
Key Statistics
Table 120: Latin American Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
Table 121: Latin American Multi-Organ Donors in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
Table 122: Latin American Living Organ Donor Per Million Population (PMP) by Country: 2013 & 2014 (includes corresponding Graph/Chart)
Table 123: Latin American Organ Transplantation by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
Table 124: Latin American Organ Transplantation Waiting List by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
B.Market Analytics
Table 125: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 126: Latin American Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 127: Latin American 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7. REST OF WORLD
Market Analysis
Table 128: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 129: Rest of World Historic Review for Organ Transplantation by Organ Type
Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 130: Rest of World 14-Year Perspective for Organ Transplantation by Organ Type
Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 22
The United States (18)
Europe (4)
- Germany (1)
- Rest of Europe (3)

Note: Product cover images may vary from those shown
4 of 5
  • Acelity L.P. Inc. (US)
  • CryoLife, Inc. (US)
  • Exactech, Inc. (US)
  • Folio Biosciences, LLC (US)
  • Dr. Franz Kohler Chemie GmbH (Germany)
  • Medtronic, plc. (Ireland)
  • Organogenesis, Inc. (US)
  • Organ Recovery Systems (US)
  • Organ Transport Systems (US)
  • XVIVO Perfusion AB (Sweden)
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll